Gijtenbeek RGP, et al. Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC). P4658. ERS 2019, 30 sept, Madrid, Spanje.
Immuuntherapie minder effectief bij NSCLC met 'druggable driver'-mutatie
jun 2019 | Immuuntherapie